Day One
Seoul, South Korea – 9/10 September 2026
The Global Lung Cancer Coalition’s Annual Members’ Meeting opened in Seoul, South Korea, with members receiving a series of detailed updates on key projects, research activity and global advocacy efforts.
Members were first updated on the work nearing completion to develop and construct the new GLCC website, which will offer improved navigation, clearer access to resources and a refreshed presentation of the Coalition’s global initiatives.
Jesme Fox, Secretary of the GLCC, provided an overview of the current status of lung cancer screening across member countries.
Key messages included:
- Momentum behind screening programmes is increasing
- There is no single pathway to implementation
- National pathways can co-exist with considerable regional variation
- The absence of a national programme does not mean an absence of activity
- Major inequalities in access remain
The Lung Cancer Policy Network showcased their latest work and encouraged members to explore their new Advocacy & Implementation section, designed to support policy engagement and practical action.
Maureen Rigney, of Go2 for Lung Cancer and a key member of the GLCC Steering Committee, updated attendees on the Coping with Lung Cancer project and outlined the work plan for the coming year.
Emma O’Dowd, of the British Thoracic Oncology Group (BTOG), delivered an encouraging presentation on “the bigger lung cancer picture”.
Her talk covered advances in earlier diagnosis, new treatment options, less invasive surgical techniques, and emerging approaches aimed at making lung cancer care even more precise and effective.
Lauren Pretorius shared insights from the Think Tank behind her organisation, Campaign for Cancer (South Africa), highlighting collaborative efforts to strengthen cancer advocacy and policy influence.
Takayuki Takahama of the West Japan Oncology Group presented on evaluating patient information through quantitative research, outlining the journey of bridging the gap between patient advocacy and clinical science.
The meeting continues to demonstrate the strength, diversity and shared commitment of GLCC’s global network as members work together to improve outcomes for people affected by lung cancer.
